Asia · Markets & Finance · CNBC-TV18

Sun Pharma Advanced Research wins ₹28 crore CENVAT credit refund case in CESTAT

Published by CNBC-TV18 · India 1 h ago

On Thursday (October 1), shares of Sun Pharma Advanced Research Company Ltd ended at ₹194.90, down by ₹2.30, or 1.17%, on the BSE.

Read the full article on CNBC-TV18 Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

Also worth reading

Business Standard

RBI MPC policy, oil prices, bond yields may drive market this week

The Economic Times

Uttarakhand raises resident doctors' stipend

Meet the 100 top-funded startups and tech companies in China

The Business Times

More asset owners may adopt ‘total portfolio approach’ to counter market concentration risk

More Hong Kong homes sell at a loss despite signs prices have bottomed: agents

The Straits Times Business

OPEC+ set to keep November oil output targets steady, sources say